Concomitant thyroid disease and primary hyperparathyroidism in patients undergoing parathyroidectomy or thyroidectomy

Area of Science:

• Endocrinology
• Surgical Oncology
• Neurosurgery

Background:

• Thyroid abnormalities are often discovered during parathyroidectomy, leading to simultaneous thyroidectomy.
• Identifying concurrent thyroid and parathyroid disease before surgery minimizes the need for reoperations.

Purpose of the Study:

• To determine the incidence of primary hyperparathyroidism (PHPT) and thyroid nodular disease in patients undergoing thyroidectomy or parathyroidectomy.
• To assess the importance of preoperative evaluation for concomitant endocrine conditions.

Main Methods:

• Retrospective review of prospectively collected data from 621 patients undergoing thyroidectomy, parathyroidectomy, or both.
• Analysis included patient referral reasons, hormone levels (TSH, PTH), fine needle aspiration (FNA), ultrasound, operation type, and final pathology.

Main Results:

• 13.5% of patients referred for thyroid disease and 26.2% referred for parathyroid disease underwent combined surgery.
• Final diagnoses revealed concomitant thyroid and parathyroid disease in 10.75% and 24.27% of these respective groups.
• Patients with primary parathyroid disease had a higher likelihood of both concomitant disease and combined surgical procedures.

Conclusions:

• Concomitant thyroid and parathyroid disease are prevalent in surgical patients.
• Thorough preoperative assessment is vital to identify these conditions and prevent surgical complications and reoperations.